GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Interpharm Holdings Inc (GREY:IPAH) » Definitions » Capex-to-Operating-Income

IPAH (Interpharm Holdings) Capex-to-Operating-Income : 0.00 (As of Dec. 2007)


View and export this data going back to 2008. Start your Free Trial

What is Interpharm Holdings Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Interpharm Holdings's Capital Expenditure for the three months ended in Dec. 2007 was $-0.55 Mil. Its Operating Income for the three months ended in Dec. 2007 was $-3.94 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Interpharm Holdings Capex-to-Operating-Income Historical Data

The historical data trend for Interpharm Holdings's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interpharm Holdings Capex-to-Operating-Income Chart

Interpharm Holdings Annual Data
Trend Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.87 - - -

Interpharm Holdings Quarterly Data
Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Interpharm Holdings's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Interpharm Holdings's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Interpharm Holdings's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Interpharm Holdings's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Interpharm Holdings's Capex-to-Operating-Income falls into.



Interpharm Holdings Capex-to-Operating-Income Calculation

Interpharm Holdings's Capex-to-Operating-Income for the fiscal year that ended in Jun. 2007 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-8.003) / -10.738
=N/A

Interpharm Holdings's Capex-to-Operating-Income for the quarter that ended in Dec. 2007 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.551) / -3.937
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Interpharm Holdings  (GREY:IPAH) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Interpharm Holdings Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Interpharm Holdings's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Interpharm Holdings Business Description

Traded in Other Exchanges
N/A
Address
75 Adams Avenue, Hauppague, NY, USA, 11788
Website
Interpharm Holdings Inc manufactures generic and over-the-counter medications. The company also pursues the development of other generic drugs in broad categories.

Interpharm Holdings Headlines

No Headlines